tiprankstipranks
BioAge Labs, Inc. (BIOA)
NASDAQ:BIOA
US Market
BIOA
BioAge Labs, Inc.
RESEARCH TOOLSreports

BioAge Labs, Inc. (BIOA) Financial Statements

100 Followers

BioAge Labs, Inc. Financial Overview

BioAge Labs, Inc.'s market cap is currently $718.51M. The company's EPS TTM is $-0.72; its P/E ratio is -4.58; BioAge Labs, Inc. is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 8.99M$ 0.00$ 0.00$ 0.00
Gross Profit$ 8.99M$ 0.00$ 0.00$ 0.00
Operating Income$ -92.78M$ -78.19M$ -48.40M$ -39.97M
EBITDA$ -92.78M$ -68.58M$ -55.90M$ -39.35M
Net Income$ -80.61M$ -71.11M$ -63.85M$ -39.72M
Balance Sheet
Cash & Short-Term Investments$ 281.10M$ 354.35M$ 21.64M$ 27.64M
Total Assets$ 294.89M$ 358.23M$ 25.92M$ 28.43M
Total Debt$ 5.56M$ 8.70M$ 53.25M$ 2.47M
Net Debt$ -183.33M$ -345.64M$ 31.61M$ -25.18M
Total Liabilities$ 22.84M$ 35.11M$ 199.32M$ 140.99M
Stockholders' Equity$ 272.05M$ 323.13M$ -173.40M$ -112.56M
Cash Flow
Free Cash Flow$ -82.35M$ -51.89M$ -37.53M$ -36.28M
Operating Cash Flow$ -81.63M$ -51.52M$ -37.36M$ -36.18M
Investing Cash Flow$ -95.22M$ -366.00K$ -266.00K$ -103.00K
Financing Cash Flow$ 11.47M$ 381.20M$ 34.94M$ 2.50M
Currency in USD

BioAge Labs, Inc. Earnings and Revenue History

Income Statement >

BioAge Labs, Inc. Debt to Assets

Balance Sheet >

BioAge Labs, Inc. Cash Flow

Cash Flow >

BioAge Labs, Inc. Forecast EPS vs Actual EPS

Earnings >